Literature DB >> 31383030

Correction to: Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia.

Ian F Harrison1, Rozalind Whitaker2, Pietro Maria Bertelli2,3, James M O'Callaghan4, Lajos Csincsik2,3, Jack A Wells4, Martina Bocchetta5, Da Ma4, Alice Fisher6, Zeshan Ahmed6, Tracey K Murray6, Michael J O'Neill6, Jonathan D Rohrer5, Mark F Lythgoe4, Imre Lengyel2,3.   

Abstract

In the original publication of this article [1], the funding acknowledgement for grant "Alzheimer Society Research Program (ASRP) from the Alzheimer Society of Canada" was missing.

Entities:  

Year:  2019        PMID: 31383030      PMCID: PMC6681477          DOI: 10.1186/s40478-019-0780-9

Source DB:  PubMed          Journal:  Acta Neuropathol Commun        ISSN: 2051-5960            Impact factor:   7.801


Correction to: Acta neuropathol commun (2019) 7: 4 https://doi.org/10.1186/s40478-018-0654-6 In the original publication of this article [1], the funding acknowledgement for grant “Alzheimer Society Research Program (ASRP) from the Alzheimer Society of Canada” was missing. In this correction article the updated funding acknowledgement is shown. The missing funding acknowledgement has been indicated in bold. The Dementia Research Centre is supported by Alzheimer’s Research UK, Brain Research Trust, and The Wolfson Foundation. This work was supported by the NIHR Queen Square Dementia Biomedical Research Unit and the NIHR UCL/H Biomedical Research Centre, the MRC UK GENFI grant and the Alzheimer’s Society. IFH is funded by a research grant from Eli Lilly and Company, and the Engineering and Physical Sciences Research Council (EPSRC) UK (EP/N034864/1). JMO’C is funded by UK Medical Research Council (MRC) Doctoral Training Grant Studentship (MR/J500422/1). LC is funded by an unrestricted grant from OPTOS Plc. Ltd. DM received a proportion of funding from EPSRC studentship from UCL’s Centre for Doctoral Training in Medical Imaging, and a proportion of funding from the Alzheimer Society of Canada through the Alzheimer Society Research Program (ASRP). JDR is supported by an MRC Clinician Scientist Fellowship (MR/M008525/1) and has received funding from the NIHR Rare Disease Translational Research Collaboration (BRC149/NS/MH). MFL receives funding from BBSRC/AstraZeneca Industrial Partnership Studentship (BB/E528979/1), the UK Regenerative Medicine Platform Safety Hub (MR/K026739/1), Eli Lilly and Company, and the EPSRC (EP/N034864/1). IL receives funding from the Bill Brown Charitable Trust, Moorfields Eye Hospital Special Trustees and Mercer Fund from Fight for Sight.
  1 in total

1.  Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia.

Authors:  Ian F Harrison; Rozalind Whitaker; Pietro Maria Bertelli; James M O'Callaghan; Lajos Csincsik; Martina Bocchetta; Da Ma; Alice Fisher; Zeshan Ahmed; Tracey K Murray; Michael J O'Neill; Jonathan D Rohrer; Mark F Lythgoe; Imre Lengyel
Journal:  Acta Neuropathol Commun       Date:  2019-01-07       Impact factor: 7.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.